Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Penning

Showing results (291-300 of 461) with videos related to

Pageof 47
Sort By:
Chemical Research in Toxicology|December 2, 2022
An End Point-Specific Framework for Read-Across Analog Selection for Human Health EffectsHolger Moustakas, Mihir S Date, Manoj Kumar, et al.
Journal of Medicinal Chemistry|February 26, 2013
Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancerAndy J Liedtke, Adegoke O Adeniji, Mo Chen, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Hormonal control of Leydig cell differentiationM P Hardy, S J Gelber, Z F Zhou, et al.
The Biochemical Journal|September 22, 2000
Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormonesT M Penning, M E Burczynski, J M Jez, et al.
Steroids|September 1, 1996
Mammalian 3 alpha-hydroxysteroid dehydrogenasesT M Penning, J E Pawlowski, B P Schlegel, et al.
The Prostate|April 4, 2009
Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsMikhail G Dozmorov, Robert E Hurst, Daniel J Culkin, et al.
Chemical Research in Toxicology|May 21, 2008
The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominanceJong-Heum Park, Stacy Gelhaus, Srilakshmi Vedantam, et al.
International Journal of Clinical and Experimental Pathology|February 4, 2010
Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumorJoseph T Azzarello, Hsueh-Kung Lin, Awet Gherezghiher, et al.
Communications Chemistry|April 29, 2024
Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degraderAngelica V Carmona, Shirisha Jonnalagadda, Alfie M Case, et al.
The Journal of Biological Chemistry|January 1, 2021
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancerIrfan Asangani, Ian A Blair, Gregory Van Duyne, et al.
Pageof 47

Showing results (291-300 of 461) with videos related to

Sort By:
Pageof 47
Chemical Research in Toxicology|December 2, 2022
An End Point-Specific Framework for Read-Across Analog Selection for Human Health EffectsHolger Moustakas, Mihir S Date, Manoj Kumar, et al.
Journal of Medicinal Chemistry|February 26, 2013
Development of potent and selective indomethacin analogues for the inhibition of AKR1C3 (Type 5 17β-hydroxysteroid dehydrogenase/prostaglandin F synthase) in castrate-resistant prostate cancerAndy J Liedtke, Adegoke O Adeniji, Mo Chen, et al.
Annals of the New York Academy of Sciences|January 1, 1991
Hormonal control of Leydig cell differentiationM P Hardy, S J Gelber, Z F Zhou, et al.
The Biochemical Journal|September 22, 2000
Human 3alpha-hydroxysteroid dehydrogenase isoforms (AKR1C1-AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormonesT M Penning, M E Burczynski, J M Jez, et al.
Steroids|September 1, 1996
Mammalian 3 alpha-hydroxysteroid dehydrogenasesT M Penning, J E Pawlowski, B P Schlegel, et al.
The Prostate|April 4, 2009
Unique patterns of molecular profiling between human prostate cancer LNCaP and PC-3 cellsMikhail G Dozmorov, Robert E Hurst, Daniel J Culkin, et al.
Chemical Research in Toxicology|May 21, 2008
The pattern of p53 mutations caused by PAH o-quinones is driven by 8-oxo-dGuo formation while the spectrum of mutations is determined by biological selection for dominanceJong-Heum Park, Stacy Gelhaus, Srilakshmi Vedantam, et al.
International Journal of Clinical and Experimental Pathology|February 4, 2010
Expression of AKR1C3 in renal cell carcinoma, papillary urothelial carcinoma, and Wilms' tumorJoseph T Azzarello, Hsueh-Kung Lin, Awet Gherezghiher, et al.
Communications Chemistry|April 29, 2024
Discovery of an Aldo-Keto reductase 1C3 (AKR1C3) degraderAngelica V Carmona, Shirisha Jonnalagadda, Alfie M Case, et al.
The Journal of Biological Chemistry|January 1, 2021
Using biochemistry and biophysics to extinguish androgen receptor signaling in prostate cancerIrfan Asangani, Ian A Blair, Gregory Van Duyne, et al.
Pageof 47